Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment

NCT05856513 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment
Pharmacokinetics

Interventions

DRUG: ZSP1273
DRUG: ZSP1273
DRUG: ZSP1273

Sponsor

Guangdong Raynovent Biotech Co., Ltd